Gagnon Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-167,414
Closed -$17M 87
2025
Q4
$17M Sell
167,414
-12,028
-7% -$966K 3.46% 7
2025
Q3
$9.82M Sell
179,442
-99,347
-36% -$4.96M 1.97% 20
2025
Q2
$14.8M Buy
278,789
+8,125
+3% +$413K 3.01% 9
2025
Q1
$11.7M Buy
270,664
+24,460
+10% +$1.24M 2.58% 14
2024
Q4
$13.8M Buy
246,204
+12,621
+5% +$785K 2.79% 11
2024
Q3
$15.9M Sell
233,583
-12,920
-5% -$729K 3.15% 8
2024
Q2
$10.4M Buy
246,503
+174,419
+242% +$9.6M 2.35% 16
2024
Q1
$4.98M Buy
72,084
+2,654
+4% +$168K 1.18% 27
2023
Q4
$5.14M Buy
69,430
+2,909
+4% +$191K 1.23% 26
2023
Q3
$4.54M Buy
66,521
+931
+1% +$79K 1.14% 28
2023
Q2
$6.16M Buy
65,590
+4,922
+8% +$384K 1.28% 27
2023
Q1
$4.11M Buy
+60,668
New +$3.9M 0.86% 30

Other funds holding EXAS

Gagnon Securities's EXAS Position: Q1 2026 in Review

Gagnon Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 167,414 shares — an estimated $17M sold.

Gagnon Securities first reported a position in EXAS in Q1 2023 and held it in 12 quarters. The position peaked at $17M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Gagnon Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Gagnon Securities sold 167,414 Exact Sciences shares in Q1 2026, an estimated $17M.
  • Gagnon Securities first reported a position in Exact Sciences in Q1 2023 and held it in 12 quarters.
  • Gagnon Securities's Exact Sciences position peaked at $17M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.